Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07313436 · ClinicalTrials.gov registry record · NA
Extended Release Protein Dosing
A NA study of Nutrition, sponsored by VitaKey.
- Recruiting
- Registry status
- NA
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT07313436: Recruiting NA study of Nutrition, sponsored by VitaKey.
NCT07313436 is a NA study of Nutrition that is actively recruiting participants, run by VitaKey. The registered enrollment target is 21 participants, below the 3,208-participant average among 22 other Nutrition trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07313436, a NA study of Nutrition, is actively recruiting participants, sponsored by VitaKey.
- RECRUITING
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal of this study is to determine the minimum dose required to elicit measurable elevation of plasma essential amino acid levels 12 hours after consuming VitaKey's extended release protein technology. The results of this study will be used to set a dose for future protein clinical studies.
Conditions Studied
Interventions
- OTHER Control
- OTHER Extended release nutritional protein
- OTHER Negative Dose
Study Locations (1)
Illinois
- Biofortis - Addison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2025-11-17 |
| Est. Completion | 2026-04 |
| Phase | NA |
What NCT07313436 shows while recruiting
NCT07313436 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 3,208-participant average among 22 other Nutrition trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Nutrition appearing as the primary indexed condition, and to 3 interventions - of which Control is the first listed.
NCT07313436 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT07313436 about?
NCT07313436 is a clinical study titled "Extended Release Protein Dosing". The overall goal of this study is to determine the minimum dose required to elicit measurable elevation of plasma essential amino acid levels 12 hours after consuming VitaKey's extended release protein technology. The results of this study will be used to set a dose for future protein clinical studi...
What is the current status of trial NCT07313436?
This trial is currently recruiting. It is a NA study. The enrollment target is 21 participants. The study started on 2025-11-17. Estimated completion is 2026-04.
What conditions does trial NCT07313436 study?
This clinical trial studies the following conditions: Nutrition.
What interventions are being tested in trial NCT07313436?
The interventions under investigation include: Control (OTHER), Extended release nutritional protein (OTHER), Negative Dose (OTHER).
Who is sponsoring clinical trial NCT07313436?
This trial is sponsored by VitaKey, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07313436 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nutrition
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07313436's enrollment target sits among peer trials
21 22nd of 22 higher than 1 of 22 other Nutrition trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Nutrition trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Salud Diabetes: A Pilot Study Comparing Lifestyle Interventions and Real-Time Continuous Glucose Monitoring
RECRUITING · NA
-
Healthy School Recognized Campus: A Hybrid Type 2 Implementation-Effectiveness Trial
RECRUITING · NA
-
Nutrition for Precision Health, Powered by the All of Us
RECRUITING · NA
-
Sleep Well Firefighters: An App-based Program to Improve Sleep, Cognition, and Behavioral Health in Firefighters
RECRUITING · NA
-
Strong Teens for Healthy Schools Change Club: A Civic Engagement Approach to Improving Physical Activity and Healthy Eating Environments
RECRUITING · NA
-
Nourish Clinical Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI